Postoperative Quadriceps Motor Power of Continuous Femoral Levobupivacaine 0.05% or 0.1%: A Prospective, Randomized Double-Blind Trial in Patients After Total Knee Arthroplasty.

Trial Profile

Postoperative Quadriceps Motor Power of Continuous Femoral Levobupivacaine 0.05% or 0.1%: A Prospective, Randomized Double-Blind Trial in Patients After Total Knee Arthroplasty.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 13 May 2016

At a glance

  • Drugs Levobupivacaine (Primary)
  • Indications Pain
  • Focus Pharmacodynamics
  • Most Recent Events

    • 16 Aug 2012 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 13 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
    • 27 Jan 2012 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top